Human immune response to a plague vaccine comprising recombinant F1 and V antigens

被引:145
作者
Williamson, ED [1 ]
Flick-Smith, HC [1 ]
LeButt, C [1 ]
Rowland, CA [1 ]
Jones, SM [1 ]
Waters, EL [1 ]
Gwyther, RJ [1 ]
Miller, J [1 ]
Packer, PJ [1 ]
Irving, M [1 ]
机构
[1] Dstl Porton Down, Salisbury SP4 0JQ, Wilts, England
关键词
D O I
10.1128/IAI.73.6.3598-3608.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The human immune response to a new recombinant plague vaccine, comprising recombinant F1 (rF1) and rV antigens, has been assessed during a phase 1 safety and immunogenicity trial in healthy volunteers. All the subjects produced specific immunoglobulin G (IgG) in serum after the priming dose, which peaked in value after the booster dose (day 21), with the exception of one individual in the lowest dose level group, who responded to rF1 only. Three subjects, found to have an anti-rV titer at screening, were excluded from the overall analysis. Human antibody functionality has been assessed by quantification of antibody competing for binding to rV in vitro and also by the transfer of protective immunity in human serum into the naive mouse. Human and macaque IgG competed for binding to rV in vitro with a mouse monoclonal antibody, previously shown to protect mice against challenge with plague, suggesting that this protective B-cell epitope on rV is conserved between these three species. Total IgG to rV in individuals and the titer of IgG competing for binding to rV correlated significantly at days 21 (r = 0.72; P < 0.001) and 28 (r = 0.82; P < 0.001). Passive transfer of protective immunity into mice also correlated significantly with total IgG titer to rF1 plus rV at days 21 (r(2) = 98.6%; P < 0.001) and 28 (r(2) = 76.8%; P < 0.03). However, no significant vaccination-related change in activation of peripheral blood mononuclear cells was detected at any time. Potential serological immune correlates of protection have been investigated, but no trends specific to vaccination could be detected in cellular markers.
引用
收藏
页码:3598 / 3608
页数:11
相关论文
共 32 条
  • [11] Protective efficacy of a fully recombinant plague vaccine in the guinea pig
    Jones, SM
    Griffin, KF
    Hodgson, I
    Williamson, ED
    [J]. VACCINE, 2003, 21 (25-26) : 3912 - 3918
  • [12] Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains
    Jones, SM
    Day, F
    Stagg, AJ
    Williamson, ED
    [J]. VACCINE, 2000, 19 (2-3) : 358 - 366
  • [13] Metapopulation dynamics of bubonic plague
    Keeling, MJ
    Gilligan, CA
    [J]. NATURE, 2000, 407 (6806) : 903 - 906
  • [14] Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague
    Leary, SEC
    Griffin, KF
    Garmory, HS
    Williamson, ED
    Titball, RW
    [J]. MICROBIAL PATHOGENESIS, 1997, 23 (03) : 167 - 179
  • [15] PLAGUE IMMUNIZATION .3. SEROLOGIC RESPONSE TO MULTIPLE INOCULATIONS OF VACCINE
    MARSHALL, JD
    CAVANAUGH, DC
    BARTELLONI, PJ
    MEYER, KF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1974, 129 : S26 - S29
  • [16] PLAGUE IMMUNIZATION .2. RELATION OF ADVERSE CLINICAL REACTIONS TO MULTIPLE IMMUNIZATIONS WITH KILLED VACCINE
    MARSHALL, JD
    BARTELLONI, PJ
    CAVANAUGH, DC
    KADULL, PJ
    MEYER, KF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1974, 129 : S19 - S25
  • [17] IMMUNOGENICITY OF PLAGUE VACCINES IN MICE AND GUINEA PIGS
    METZ, EV
    EISLER, DM
    HOTTLE, GA
    [J]. APPLIED MICROBIOLOGY, 1971, 22 (01) : 84 - +
  • [18] MEYER K F, 1953, Bull World Health Organ, V9, P619
  • [19] PLAGUE IMMUNIZATION .6. VACCINATION WITH FRACTION I ANTIGEN OF YERSINIA-PESTIS
    MEYER, KF
    HIGHTOWER, JA
    MCCRUMB, FR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1974, 129 : S41 - S45
  • [20] PLAGUE IMMUNIZATION .1. PAST AND PRESENT TRENDS
    MEYER, KF
    CAVANAUGH, DC
    BARTELLONI, PJ
    MARSHALL, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1974, 129 : S13 - S18